Table 1 Comparision of clinical features of atypical and typical MYC/BCL2 DHL
Features | Atypical MYC/BCL2 DHL | MYC/BCL2 DHL |
|---|---|---|
Age (years), median (range) | 60 (6–82) | 61 (18–87) |
Age>60 (years) | 53% (21/41) | 55% (42/76) |
Male:female | 21:19 | 47:29 |
Previous FL/B-NHL | 23% (9/40) | 27% (20/72) |
BM positive | 40% (8/20) | 55% (38/69) |
CNS positive | 9% (1/11) | 20% (7/35) |
Extranodal sites≥2 | 52% (14/27) | 58% (39/67) |
Elevated serum LDH* | 55% (16/29) | 79% (52/66) |
Stage III or IV | 71% (22/31) | 84% (62/74) |
High IPI score | 60% (18/30) | 76% (54/71) |